TSX News -
AirBoss Announces Details of Annual General Meeting
NEWMARKET, Ontario, April 27, 2020 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS) (the “Company” or “AirBoss”) today announced […]
Exagen to Announce First Quarter Financial Results on May 11, 2020
SAN DIEGO, April 27, 2020 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients […]
Adverum Biotechnologies Doses First Patient in Cohort 4 of OPTIC Phase 1 Clinical Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD
Patients in Cohort 4 of OPTIC will Receive a Single ADVM-022 Dose of 6 x 10 ^11 vg/eyeREDWOOD CITY, Calif., April […]
Lightbridge Signs Cooperative R&D Agreement with the U.S. Department of Energy’s Gateway for Accelerated Innovation in Nuclear (GAIN) Program
RESTON, Va., April 27, 2020 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge,” or the “Company”) (NASDAQ: LTBR), an advanced nuclear fuel […]
DLH to Announce Second Quarter FY20 Financial Results
ATLANTA, April 27, 2020 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and […]
Atossa Therapeutics Contracts with NYC Health + Hospitals/Metropolitan for COVID-19 HOPE Clinical Study
SEATTLE, April 27, 2020 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and […]
DAVIDsTEA Provides Business and Financial Performance Update
MONTREAL, April 27, 2020 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (Nasdaq:DTEA) (“DAVIDsTEA” or the “Company”), a leading tea merchant in North […]
Core-Mark Announces First Quarter 2020 Investor Call
WESTLAKE, Texas, April 27, 2020 (GLOBE NEWSWIRE) — Core-Mark Holding Company, Inc. (NASDAQ: CORE), announced today that it will release […]
CytomX Therapeutics to Announce First Quarter 2020 Financial Results
SOUTH SAN FRANCISCO, Calif., April 27, 2020 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company […]
electroCore Provides Update on COVID-19 Clinical Initiatives
Randomized controlled investigator-initiated trial (IIT) of non-invasive vagus nerve stimulation (nVNS) therapy currently enrolling COVID-19 patients in SpainPeer-reviewed paper, “Use […]
